Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (211-220 of 607) with videos related to

Pageof 61
Sort By:
Clinical and Experimental Rheumatology|September 19, 2008
Inhaled iloprost for the treatment of Raynaud's phenomenonA Pakozdi, K Howell, H Wilson, et al.
Arthritis and Rheumatism|June 30, 2007
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory modelLynne Shand, Mark Lunt, Svetlana Nihtyanova, et al.
QJM : Monthly Journal of the Association of Physicians|May 23, 2013
Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibilityH Penn, N Quillinan, K Khan, et al.
ACR Open Rheumatology|January 11, 2026
Lymphocyte Activation Gene 3 Regulation of Profibrotic Cytokines and Type I Collagen Production in Patients With Systemic SclerosisMaithri Aspari, Stinne Greisen, Malene Hvid, et al.
JCI Insight|April 15, 2025
Characterization of a pathogenic nonmigratory fibroblast population in systemic sclerosis skinKristina En Clark, Shiwen Xu, Moustafa Attar, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblastsS Xu, C P Denton, A Holmes, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Autologous fat transfer in the successful treatment of upper limb linear morphoeaSebastiano Mura, Alessandra Fin, Pier Camillo Parodi, et al.
Rheumatology (Oxford, England)|June 13, 2018
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung diseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Arthritis and Rheumatism|January 1, 2000
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialM Dziadzio, C P Denton, R Smith, et al.
Arthritis Research & Therapy|April 20, 2010
Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of sclerodermaEmma C Derrett-Smith, Audrey Dooley, Korsa Khan, et al.
Pageof 61

Showing results (211-220 of 607) with videos related to

Sort By:
Pageof 61
Clinical and Experimental Rheumatology|September 19, 2008
Inhaled iloprost for the treatment of Raynaud's phenomenonA Pakozdi, K Howell, H Wilson, et al.
Arthritis and Rheumatism|June 30, 2007
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory modelLynne Shand, Mark Lunt, Svetlana Nihtyanova, et al.
QJM : Monthly Journal of the Association of Physicians|May 23, 2013
Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibilityH Penn, N Quillinan, K Khan, et al.
ACR Open Rheumatology|January 11, 2026
Lymphocyte Activation Gene 3 Regulation of Profibrotic Cytokines and Type I Collagen Production in Patients With Systemic SclerosisMaithri Aspari, Stinne Greisen, Malene Hvid, et al.
JCI Insight|April 15, 2025
Characterization of a pathogenic nonmigratory fibroblast population in systemic sclerosis skinKristina En Clark, Shiwen Xu, Moustafa Attar, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblastsS Xu, C P Denton, A Holmes, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Autologous fat transfer in the successful treatment of upper limb linear morphoeaSebastiano Mura, Alessandra Fin, Pier Camillo Parodi, et al.
Rheumatology (Oxford, England)|June 13, 2018
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung diseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Arthritis and Rheumatism|January 1, 2000
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialM Dziadzio, C P Denton, R Smith, et al.
Arthritis Research & Therapy|April 20, 2010
Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of sclerodermaEmma C Derrett-Smith, Audrey Dooley, Korsa Khan, et al.
Pageof 61